header logo image


Page 980«..1020..979980981982..9901,000..»

MSK conditions must be central to multimorbidity plans, says Arthritis Research UK – Chartered Society of Physiotherapy

August 1st, 2017 7:49 pm

Arthritis Research UK says by 2018 there will be 2.9m people living with multimorbidity

The call is made in a report by Arthritis Research UK exploring why MSK conditions must be included in future plans to address multimorbidity.

Arthritis Research UK says that NHS England should ensure that metrics and tools used in multimorbidity programmes include monitoring and measuring of pain and its impact on functional abilities and capability to manage.

Research funders, such as the National Institute for Health Research, should work with partners to ensure there is a flourishing research agenda covering multimorbidity, which includes common conditions such as MSK conditions.

Good MSK health underpins living well and independently with multimorbidity, but MSK conditions are too often overlooked, the charity says.

Meanwhile MSK conditions affect around 10 million people across the UK, and are often found in people with other long-term conditions.

The report reveals that among people over 45 years with a major long-term condition, more than 30 per cent also have arthritis. By 65, almost half of people with a heart, lung or mental health problem also have arthritis.

Conversely, 80 per cent of people with osteoarthritis have at least one other long-term condition such as hypertension, cardiovascular disease or depression.

Arthritis Research says it is essential to recognise the interaction between MSK conditions and other health problems.

Any long-term condition is associated with a drop in quality of life, but when arthritis or back pain is part of multimorbidity, the drop is greater. The pain and functional limitations of arthritis make it harder to cope when living with other long-term conditions.

Professor Peter Kay, NHS Englands national clinical director of MSK Services said: We must work across systems to ensure we have the appropriate data collected and available to understand the numbers and requirements of people living with multiple long-term conditions.

View original post here:
MSK conditions must be central to multimorbidity plans, says Arthritis Research UK - Chartered Society of Physiotherapy

Read More...

Arthritis charities set to merge later this year – Charity Today News

August 1st, 2017 7:49 pm

ARTHRITIS Care and Arthritis Research UK have announced that they are to merge to help over 10 million people living with arthritis in the UK.

The charities say that they began discussions at the turn of the year and that due diligence is now underway.

In a joint statement Dr Liam OToole, chief executive of Arthritis Research UK and Judi Rhys, chief executive of Arthritis Care, said Currently there are too many people living with the pain, fatigue and isolation caused by arthritis. The two charities are doing great work to address their needs, and we know we can have a greater impact on peoples lives by creating one organisation.

The aspirations of people with arthritis are changing and it is vital that we continue to meet their expectations. We can stand together with one louder voice to change attitudes and press for change. We can transform our care, support and information services so that many more people can build their knowledge, skills and resilience to live well with arthritis. We will continue our fight to find better treatments and even a cure and well now be able to offer our supporters, members, volunteers, branches and groups the opportunity to join patient-focussed clinical trials and influence the research agenda.We believe that this is a truly exciting step.

The charities hope to come together in a single organisation in October this year.

Follow this link:
Arthritis charities set to merge later this year - Charity Today News

Read More...

More Americans Than Ever Say Polygamy Is Morally Acceptable – HuffPost

August 1st, 2017 7:49 pm

The practice of polygamy, or having more than one spouse at the same time, is illegal in all 50 states. But the percentage of Americans who say the practice is morally acceptable reached an all-time high this year, according to a recent Gallup poll.

Gallup has measured American attitudes toward a number of social issues and behaviors, such as divorce, same-sex relations, and stem cell research, since 2001. In that time, the percentage of Americans who find polygamy to be morally acceptable has risen from seven to 17 percent.

Of all the issues and behaviors Gallup asked about, polygamy is among those to gain the most ground on moral acceptance since 2001, after same-sex relations, having a baby out of wedlock, sex between an unmarried man and woman and divorce.

Gallup initially attributed a 2011 bump in Americans acceptance of polygamy to a change in the wording of the question.Before 2011, Gallup defined polygamy as being when a husband has more than one wife at the same time.

But polygamy is actually a gender-neutral term that refers to the practice of having more than one spouse at a time. The majority of polygamous societies around the globe practice polygyny, when a man marries more than one woman. Another form of polygamy, called polyandry, refers to when a woman has more than one husband.

In 2011, Gallup changed its definition to reflect the terms gender-neutrality, identifying polygamy as when a married person has more than one spouse at the same time.

The change in wording coincided with a bump in the percentage of Americans who found polygamy morally acceptable but the continued rise likely has little to do with semantics, Gallup analyst Andrew Dugan wrote in a recent article.

The growing moral acceptance of polygamy may be part of a broaderleftward shifton moral issues, Dugan wrote, as well as increased depictions of the marital practice in popular media.

In the wake of the Supreme Courts 2015 ruling legalizing same sex marriage in all 50 states, scholar and cultural commentator Fredrik deBoer argued in article on Politico that polygamy would be the next horizon of social liberalism.DeBoer seemed to echo in positive terms what many social conservatives ominously warned: that legal changes to so-called traditional marriage could lead to anything even group marriage.

Within the U.S., though, polygamy tends to be most common among highly religious groups, including conservative Muslim immigrants from parts of Africa and Asia and the insular, isolated Fundamentalist Church of Jesus Christ of Latter-Day Saints.

The latter, a religious sect that broke off from the Church of Jesus Christ of Latter-Day Saints or Mormon Church in the 1930s, has been associated with the sexual abuse of children. Its leader,Warren Jeffs, was sentenced to life in prison in 2011 for having sex with underage girls.

In addition to several high-profile cases of child abuse linked to polygamous groups, plural marriage has also been linked to genetic disorders, child development problems for the offspring of such unions, a number of social issues including rape and substance abuse in societies where theres a disproportionate number of unmarried men as a result of polygyny, and even an increased risk of heart disease for polygamous men.

Even with polygamys problems and traditionally religious associations, Gallup found that acceptance of the practice is highest among non-religious Americans. Thirty-two percent of Americans who arent affiliated with any religion or who arent religious at all said polygamy ismorally acceptable.

Americans who identify as Christian were more likely than the overall same average to find the practice to be morally intolerable, even given the Biblical precedent for polygamy.

The Morning Email

Wake up to the day's most important news.

See the original post here:
More Americans Than Ever Say Polygamy Is Morally Acceptable - HuffPost

Read More...

Charlie Gard Dies, Leaving a Legacy of Thorny Ethics Questions – New York Times

August 1st, 2017 7:49 pm

Our final wish

They lost their fight. On Thursday, Ms. Yates, who works as a caregiver, said in statement that the hospital had denied us our final wish.

Most people wont ever have to go through what we have been through, she said. Weve had no control over our sons life and no control over our sons death.

But the doctors treating Charlie at Great Ormond Street Hospital in central London countered that the risk of an unplanned and chaotic end to Charlies life at home was unthinkable. For months, the hospital had argued that he had irreversible brain damage, that the life support should be removed and that he should be allowed the right to die with dignity.

We deeply regret that profound and heartfelt differences between Charlies doctors and his parents have played out in court over such a protracted period, the hospital said in a statement. We will never do anything that could cause our patients unnecessary and prolonged suffering.

The case laid bare several issues, among them: Should parents or doctors or the courts have the final say in irreconcilable disputes over the treatment of sick children? And at what point should the limits of medicine be recognized and the parents of an infant be compelled to let go?

Biomedical ethicists said the case offered a cautionary tale of how a legal battle, scrutiny by the global news media and intractable differences between parents and doctors can spiral out of control in the social media age. Both the hospital and the parents in the Gard case dug in, their arguments playing out on Facebook and Twitter and capturing the attention of world figures including President Trump and Pope Francis.

The pope posted a message on his personal Twitter account shortly after news broke of the infants death. I entrust little Charlie to the Father and pray for his parents and all those who loved him, the tweet said.

Dr. Robert D. Truog, a physician at the pediatric intensive-care unit at Boston Childrens Hospital and the director of the Center for Bioethics at Harvard Medical School, said that Charlies parents were like parents all over the world they were willing to do absolutely anything to save the life of their child.

He added: They were the victims, not the cause, of this tragic situation.

The parents raw emotions played out in the courtroom, where Ms. Yates broke down in tears of frustration, at one point shouting, What if it was your child? before fleeing the room. At another moment, Mr. Gard, a mailroom worker, cried out, Evil after a hospital lawyer spoke.

On several occasions, both parents stormed out of the courtroom. Some of the lawyers and journalists covering the case were reduced to tears.

The case went through several courts, including Britains Supreme Court and the European Court of Human Rights, which backed the hospitals views, in part because experts said Charlie could be suffering. His parents insisted he was not.

Some American conservatives seized on the case as a warning of the pitfalls of socialized medicine and the abrogation of parental rights, even as the High Court judge presiding over the case, Nicholas Francis, countered that to make a scapegoat out of Britains National Health Service was nonsensical.

In most cases, medical experts say, doctors decide when to remove life support from an incurably ill child, in consultation with parents, and these cases rarely wind up in court. But in Britain, the courts are the final arbiter when irreconcilable disputes arise.

Charlie also became a powerful symbol for anti-abortion groups the world over. Protesters picketed outside Great Ormond Street Hospital, and Judge Francis denounced death threats against hospital staff members.

The case also spurred questions about the wisdom of offering parents the hope of experimental treatment when faced with an incurable disease. That debate took center stage after Dr. Michio Hirano, a neurologist at Columbia University Medical Center in New York, offered Charlies parents a ray of hope that an experimental treatment known as nucleoside therapy could improve Charlies condition.

The treatment had been tested on mice and on 18 people with a mutation in a gene known as TK2. But it had never been tried on someone with Charlies particularly debilitating form of mitochondrial DNA depletion syndrome, which is caused by a different genetic mutation.

During an often-acrimonious and emotional High Court hearing this month, Charlies parents argued that he should be allowed to receive the experimental treatment. But lawyers for Great Ormond Street Hospital countered that Dr. Hirano had held out hope without even examining the child or reviewing his full medical charts.

(Dr. Hirano said in a statement he had been contacted by the parents and agreed to speak with Charlies doctors to determine whether the experimental therapy he was developing could help improve the childs condition).

When Dr. Hirano traveled to London this month to examine Charlie, about six months after he had first been invited, a series of scans showed that the boy had suffered muscular atrophy, that the damage was irreversible and that treatment would be futile.

Ms. Yates criticized the hospital, saying it had dragged its feet about the treatment until it was too late.

The hospital consistently stood by its contention that treatment would have been useless and that Charlie had irreversible brain damage.

If Charlie has had a relationship with the world around him since his best interests were determined, it has been one of suffering, it said in a statement.

Dominic Wilkinson, a neonatologist and professor of medical ethics at Oxford University, said the case offered a tragic lesson about the risks of doctors offering uncertain hope to desperate parents. At the same time, he said, the case underscored the importance of mediation during a dispute about treatment, noting that the communication breakdown in the Gard case had all the attributes of a messy divorce.

To let a child go is incredibly difficult, but it is also incredibly important, he said. It is heartbreaking, but we have to know when to say enough is enough.

Dr. Truog of Harvard Medical School said the parents legal battle had tapped into the health care debate in the United States, and was being seized upon by some to affirm a money-driven system in which patients who have the means can pursue experimental treatments, even if the chances of success are slim. But he said experimental treatments must be weighed against the benefits for society as a whole.

In the United States, no one can demand nonbeneficial treatments simply by claiming they are paying out of pocket, he wrote in a recent article on the Gard case in The Journal of the American Medical Association.

It would be extremely rare for a hospital in the United States to admit patients for the exclusive purpose of receiving homeopathic therapy or unproven stem cell infusions, he wrote, regardless of how much the patient paid.

The parents now face coming to terms with Charlies death. Addressing the court this past week, Ms. Yates acknowledged that this would not be easy.

We are struggling to find any comfort or peace with all this, she said. But one thing that does give us the slightest bit of comfort is that we truly believe that Charlie may have been too special for this cruel world.

Go here to read the rest:
Charlie Gard Dies, Leaving a Legacy of Thorny Ethics Questions - New York Times

Read More...

India needs biannual amendment to Stem Cell Rules, Section 8 of Rules controversial: Dr Totey – pharmabiz.com

August 1st, 2017 7:49 pm

India needs stem cell guidelines which can be amended biannually, said Dr Satish Totey, founder, chairman & managing director, Aureostem Research Pvt Ltd.

There cannot be a permanent set of guidelines. Every year we should make new draft guideline and seek public opinion. This must be discontinued immediately since valuable time and money are invested in the same. Instead it should be amended biannually, Totey told Pharmabiz.

Although the recent guidelines are comprehensive and may ensure patients get reliable and safe stem cell products in India in near future, yet the controversial section of this is Section 8. The section defines level of stem cell manipulation as minimum and major which is absolutely unnecessary and gives clear escape route to push unapproved stem cell for therapy by the clinicians, he said.

Desperate patients do not understand this terminology and often misled by the clinicians. For instance adipose derived stromal vascular fraction (AD-SVF) or bone marrow derived mononuclear cells (BM-MNC) which is minimal manipulated cells are being extensively used by the clinicians and giving impression to the patients that it do not require any clinical trials.

Now several clinicians use minimal manipulated cells for transplanting in retinas or in the brain without knowing its safety and efficacy. Much of what is being injected through minimum manipulated cells are not even stem cells. Moreover, one that come from fat or bone marrow are not capable of living in the human body for more than a day. There are several reports that patients become blind after such transplants, explained Dr Totey.

Another aspect which was totally ignored in the guideline is stem cell devices. Several clinicians use stem cell devices routinely in India which has limited approval from US FDA even for specific clinical conditions in the US. Therefore, such devices cannot be used in India. But clinicians are seen to mislead patients and giving impression that they have US FDA approval for stem cell therapy. This is a most dangerous procedure where, clinician can treat any condition without even having clinical speciality. For example, cosmetologists are now treating neurological or cardiac conditions. One of the key issues are oversight. But in these cases it is not just about desperate patients losing money but the genuine and tangible harms being done in the absence of oversight, he said.

Real progress in stem cell research and the development of cellular pharmaceuticals is not going to result from clinics making dramatic marketing claims. True progress requires extensive basic and pre-clinical research. It should be backed by carefully designed and properly conducted randomized clinical trials to ensure high-quality safety and efficacy data is generated.

Conducting such research in an ethical, scientific, and legal manner is difficult, costly, time-consuming, but necessary. More than 300 stem cell clinics that are operating in India are making dramatic advertising claims about stem cell treatments, but in most cases they have no evidence to support their hard-sell marketing, said Dr Totey.

See the article here:
India needs biannual amendment to Stem Cell Rules, Section 8 of Rules controversial: Dr Totey - pharmabiz.com

Read More...

Regenerative Medicine Market in the US to Grow at a CAGR of 23.5 … – Business Wire (press release)

August 1st, 2017 7:48 pm

DUBLIN--(BUSINESS WIRE)--The "Regenerative Medicine Market in the US 2017-2021" report has been added to Research and Markets' offering.

The Regenerative Medicine Market in the US to grow at a CAGR of 23.53% during the period 2017-2021.

The report, Regenerative Medicine Market in the US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is the increasing strategic alliances. Major vendors are entering into strategic alliances with other vendors for drug development and manufacturing. The trend is anticipated during the forecast period. Leading vendors in the market are undertaking M&A to strengthen their global position and to improve their commercial capabilities. Through increasing strategic alliances, many companies are receiving upfront and royalty payment, which encourages many small companies to involve into R&D and develop novel regenerative medicine products.

According to the report, one of the major drivers for this market is CVD and diabetes in young adult and aging population. CVD is a common disease in the older population; however, it is growing high among young adults owing to lifestyle and over-indulgement in junk foods. A combined study conducted by the Department of Clinical and Experimental Medicine, University of Florence; Department of Health Sciences, University of Milano-Bicocca; and Department of Cardiology, S. Luca Hospital, IRCCS Istituto Auxologico Italiano, Italy in 2015, found that uncontrolled blood pressure increases the risk of CVDs such as stroke and heart attack.

Key vendors

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Pipeline portfolio

PART 07: Market segmentation by product

PART 08: Market segmentation by application

PART 09: Market segmentation by end-user

PART 10: Decision framework

PART 11: Drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

PART 14: Key vendor analysis

For more information about this report visit https://www.researchandmarkets.com/research/8dnt7z/regenerative

See the original post here:
Regenerative Medicine Market in the US to Grow at a CAGR of 23.5 ... - Business Wire (press release)

Read More...

Stem Cell Therapy can provide a surgery-free solution to knee and shoulder issues – Colorado Springs Gazette

August 1st, 2017 2:44 am

Springs Integrated Health offers leading-edge, all-natural medical care. The center provides services intended to get to the root of patient issues and deliver real, lasting results in the simplest, most effective way. Instead of covering up symptoms with medications, the clinic breaks down health into obtainable goals that can optimize the wellness of each and every patient. Services include chiropractic, hormone lab testing, physical rehabilitation, Supartz therapy, trigger point therapy, FAR infrared sauna, stem cell therapy and more.

There was a time when stem cell therapy was out of reach for most people, but it has become increasingly accessible in recent years; and a go-to solution for a range of physiological complications. Stem cells are blank cells in the body that can become any tissue, whether that be knee tissue, bone tissue, cartilage, organ tissue stem cells can become whatever they are closest and nearest to, said Tiffany Graham, DC of Springs Integrated Health. So when you inject them into a joint thats damaged the body is always healing itself anyway it can create new tissue where there has been damage.

Stem cell therapy has been used for decades in Europe, and in the United States has been used by Peyton Manning, Tiger Woods, and many NFL players and other professional athletes. Although stem cells were initially reserved for the ultra wealthy, they have since become both affordable and accessible; and many patients are opting for them over lengthy and expensive knee and shoulder surgeries. One in 400 total knee replacements result in fatal infection, and those that do not end up in infection still prove to have an extensive recovery time. Stem cell therapy is safe and quick, and people can feel results in as little as one week. Further, the company Springs Integrated Health utilizes for stem cells has given more than 50,000 injections with zero side effects and zero adverse reactions.

There are two different types of stem cells. The first is adult stem cells, where patients take their own bone marrow, fat or blood; spin it down; and re-inject into the joints. Thats not what is used at Springs Integrated Health, because its a long procedure that can be very painful and expensive. The second is amniotic stem cells, which are from donated placental tissue. This tissue comes from mothers who have planned c-sections, and who have elected to donate their placenta to science. The stem cells have been thoroughly tested and are clear of all antigens, so there is no risk for rejection or infection. The stem cells used at Springs Integrated Health are 100 percent ethically-sourced, and are not embryonic stem cells, which come from aborted fetal tissue, said Graham.

Rick Paine is a beaming example of the efficacy of stem cell therapy. He is an avid runner and hiker, and coached swimming at the University of Nebraska for 17 years. He was also an Olympic Head Coach in Australia in 2000. Eight years ago, he wore his left knee out and had to get a knee replacement, and it took two to three years to recover. About two years ago, his right knee was becoming worn out, and he did not want to go through the another knee surgery, because it was a very unpleasant experience for him. He was seeing an active release therapist who was helping, but he still had trouble with downhill on hikes, walking on the golf course and doing the everyday activities that make him happy.

Paine had been seeing Dr. Graham for about a year and a half before deciding to commence with stem cell therapy for his torn medial meniscus on the right knee in November 2016. At first I was skeptical, but I thought, lets give it a shot, Paine said. The procedure was quick and pretty painless, and it only took about a month after the injection for my knee to feel really good. He cautions that although the knee may feel great in a month or less, its essential to still take it easy, and give the tissue time to grow before becoming physically active.

Before I got stem cells, I couldnt squat to pick up a ball on the golf course but since getting the stem cells I can definitely do that. Im 65 years old, and a surgery would have taken me out of hiking for two to three years, but with this, it was only three months until I was hiking again, said Paine. We took X-rays a few months ago, and there has been significant improvement in my knee. I didnt expect to see that, I thought it was too good to be true, but Im living proof that stem cell therapy works.

Paine shared that now, eight months after his procedure, his knee still feels perfect. He admits that its not like having a brand new knee, but he has no issues whatsoever with downhill, uphill or bending down. I knew I wanted to do at least one more 14er, and didnt think it would be possible, but stem cells have definitely allowed me to do that. Paine is now gearing up for a 12 mile hike from Crested Butte to Aspen, a hike he couldnt have even considered before stem cells. I wish we had stem cells way back when, because it would have saved a lot of athletes careers.

To receive a complimentary consultation, or to attend an upcoming, free informational seminar at Springs Integrated Health, call 719-301-6649 or visit SpringsIntegratedHealth.com.

Springs Integrated Health is located at 1712 W. Uintah St., Colorado Springs. Hours are Monday, 10 a.m. to 12:30 p.m. and 3 to 6 p.m.; Tuesday, 3 to 6 p.m.; Wednesday, 10 a.m. to 12:30 p.m. and 3 to 6 p.m.; Thursday, 3 to 6 p.m.; and Friday 8 to 10 a.m.

See the article here:
Stem Cell Therapy can provide a surgery-free solution to knee and shoulder issues - Colorado Springs Gazette

Read More...

Regenerative Medicine – AABB

August 1st, 2017 2:44 am

Regenerative medicine may be defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function. This field holds the promise of regenerating damaged tissues and organs in the body by replacing damaged tissue or by stimulating the body's own repair mechanisms to heal tissues or organs. Regenerative medicine also may enable scientists to grow tissues and organs in the laboratory and safely implant them when the body is unable to heal itself. Current estimates indicate that approximately one in three Americans could potentially benefit from regenerative medicine.

Regenerative Medicine refers to a group of biomedical approaches to clinical therapies that may involve the use of stem cells. Examples include cell therapies (the injection of stem cells or progenitor cells); immunomodulation therapy (regeneration by biologically active molecules administered alone or as secretions by infused cells); and tissue engineering (transplantation of laboratory grown organs and tissues). While covering a broad range of applications, in practice the latter term is closely associated with applications that repair or replace portions of or whole tissues (i.e., bone, cartilage, blood vessels, bladder, skin). Often, the tissues involved require certain mechanical and structural properties for proper functioning. The term has also been applied to efforts to perform specific biochemical functions using cells within an artificially-created support system (e.g., artificial pancreas or liver).

Cord blood stem cells are being explored in several applications including Type 1 diabetes to determine if the cells can slow the loss of insulin production in children; cardiovascular repair to observe whether cells selectively migrate to injured cardiac tissue, improve function and blood flow at the site of injury and improve overall heart function; and central nervous system applications to assess whether cells migrate to the area of brain injury alleviating mobility related symptoms, and repair damaged brain tissue (such as that experienced with cerebral palsy). Cord blood stem cells likely will be an important resource as medicine advances toward harnessing the body's own cells for treatment. Because a person's own (autologous) stem cells can be infused back into that individual without being rejected by the body's immune system, autologous cord blood stem cells have become an increasingly important focus of regenerative medicine research.

Regenerative medicine has made its way into clinical practice with the use of materials that are able to assist in the healing process by releasing growth factors and cytokines back into the damaged tissue (e.g., (chronic) wound healing). As additional applications are researched, the fields of regenerative medicine and cellular therapies will continue to merge and expand, potentially treating many disease conditions and improving health for a variety of diseases and health conditions.

Read the original here:
Regenerative Medicine - AABB

Read More...

With New Biotech Institute, Manchester Aims to Be Hub for … – Nhpr – New Hampshire Public Radio

August 1st, 2017 2:44 am

Dean Kamen brought the world the Segway and helped to transform New Hampshire's Millyard from a hollowed-out manufacturing strip to a growing tech hub. Now, he's setting his sights on making Manchester a hub for a whole new field of medicine.

It sounds like the kind of stuff that at one time was relegated to science fiction. An organ, grown from scratch, to replace one at risk for renal failure. A new, fully functioning limb for a soldier who lost his to combat.

But that's exactly the vision at the heart of the Advanced Regenerative Manufacturing Institute, or BioFabUSA -- a multimillion-dollar partnership led by Kamen and the Department of Defenseto come up with new approaches to biotechnology.

ARMI (pronounced like "army") launched primarily to help soldiers, but Kamen sees wide-reaching potential for patients across the board.

"If you had a choice of, you could treat my end-stage renal failure by sending me to a dialysis center three days a week for the rest of my life, or you can cure it, by giving me a replacement organ, which would you prefer? And if you could prevent the problem in the first place, which would you prefer?" Kamen said at an ARMI launch event in Manchester on Friday. "So, ironically this is one of those rare places where thetechnologythat we're developing is one that is going to give you a betteroutcome, but it also lowers the cost."

Kamen nabbed a former top official at the FDA to get the institute up and running, and he said he's secured more than $200 million in funding -- in addition to the $80 million the Department of Defense put up to launch the effort.

"We told the Department of Defense within five years, we will have products that are being placed in or on people to cure conditions that are a result of what's going on in this place," Kamen said. "I'd like to think some of them are sooner than that, but that's our goal."

And the inventor's not the only one excited about it.

"I love it," said Gov. Chris Sununu, one of several local dignitaries on hand for the launch. "Look, anything I can do to attract more geeks to New Hampshire, being a former geek myself."

Sununu was joined at the launch event by Sens. Maggie Hassan and Jeanne Shaheen, former Gov. John Lynch, former Sen. Kelly Ayotte and a number of other top names in the state's political, business and tech scenes -- the takeaway being, policymakers are seeing this as a big deal, and a big get for the Granite State.

More here:
With New Biotech Institute, Manchester Aims to Be Hub for ... - Nhpr - New Hampshire Public Radio

Read More...

Regenerative medicine startup Rodeo Therapeutics raises $5.9M for … – GeekWire

August 1st, 2017 2:44 am

Dr. Sanford Markowitz, founder of Rodeo Therapeutics. (Case Western Reserve University Photo)

If you could write a medical wish-list of futuristic technologies, regenerating tissue would be pretty high up there. It could do things like treat a variety of inflammatory conditions and even help cancer patients regrow healthy cells.

A new Seattle-based biotech startup, Rodeo Therapeutics, is hoping its technology can make tissue regeneration a reality, and it has just raised a $5.9 million Series A round from Seattle-based biotech fund Accelerator Corporationto make it happen.

The general idea is simple: Rodeo is hoping to use small-molecule therapies a category most drugs fall into that stimulate the bodys natural regeneration process, like when a skinned knee heals.

Its first focus is to develop a treatmentfor inflammatory bowel disease and one that can help cancer patients cells grow quickly following stem cell transplants.

But those goals are just the beginning.

The ability to stimulate the bodys natural processes for tissue regeneration and repair has broad therapeutic potential in disease settings such as ulcerative colitis and in hemopoietic recovery following bone marrow transplantation,said Rodeo Therapeutics founder and cancer researcher Dr.Sanford Markowitz. Rodeo Therapeutics is focused on developing small-molecule therapies that stimulate these processes and enable new approaches to address serious medical conditions that today have a substantial unmet medical need.

The company is currently working on drugs that inhibit an enzyme called 15-PGDH, which has been shown to speed up regenerative processes.

The startup was founded by Markowitz and Dr. Stanton Gerson, researchers at Case Western University, along with Dr.Joseph Ready, a researcher at the University of Texas Southwestern Medical Center.

Its technology is based on their work. Markowitz is an expert in gastrointestinal cancers, where inflammation can cause serious problems; Dr. Gerson specializes in stem cell and genetic research along with gene therapies and cancer drug development; and Dr. Ready works in regenerative medicine and cancer, specifically synthetic and medicinal chemistry.

The startups corporate office is currently in Accelerator Corporations facilities in Seattle, with its founders in Dallas and Cleveland. Rodeos early operations will be overseen by Accelerator, and the funds CEO Thong Le is currently servingas Rodeos CEO.

Visit link:
Regenerative medicine startup Rodeo Therapeutics raises $5.9M for ... - GeekWire

Read More...

The Big Deal About Stem Cell Therapies and Regenerative Medicine – PR Newswire (press release)

August 1st, 2017 2:44 am

However, when looking at this great promise in terms of return on investment, let us be completely honest, most early stage stem cell investors have lost their shirts. We are now more than twenty years removed from the earliest commercial stem cell companies that were founded in the late 1980's, went public in the late 1990's and who were once seen as an exciting investment opportunity, but ended up being a huge disappointment.

So, should investors still be interested in regenerative medicine? After all, stem cells have largely produced failures and unregulated stem cell clinics marketing unproven therapies are taking over. The answer is a resounding yes, but the dot-com like era of regenerative medicine, which led investors to pour money into anything and anyone marketing a cell therapy is over. Investors will need to look at companies solving issues with stem cells or those taking a completely new approach.

One company that is looking to address many of the issues with stem cell therapies, as well as developing another approach to regenerative medicine is Endonovo Therapeutics, Inc. (OTCQB: ENDV). On the stem cell front, ENDV is using its Time Varying Electromagnetic Fields (TVEMF) technology, originally developed at the National Aeronautics and Space Administration (NASA) to expand and activate stem cells to produce more biologically potent cell therapies. However, more importantly, ENDV is developing a non-invasive medical device that would render many of the cell therapies currently under development obsolete. These devices, called Electroceuticals, harness the electrical signals that our cells and nerves use to control the immune and regenerative response to treat inflammatory and degenerative diseases. ENDV is developing this exciting technology for treating and preventing heart failure following a heart attack, to treat chronic kidney disease, peripheral artery disease and non-alcoholic steatohepatitis (NASH).

Another small biotech company like ENDV working on electric treatments for diseases is Pulse Biosciences (NASDAQ: PLSE), whose Nano-Pulse Stimulation (NPS) technology uses nano second electric pulses to illicit an immune response for the treatment of cancer. PLSE recently announced the treatment of its first patient in a study to evaluate the safety and efficacy of its novel NPS technology for seborrheic keratosis (SK) lesions. SK is one of the most common types of skin lesions, affecting more than 80 million patients in the United States. Additionally, PLSE announced that it will host its quarterly investor conference call on July 27, 2017, at 1:30 p.m. PDT / 4:30 p.m. EDT. The company will provide an update on the clinical advancement of the PulseTx[TM] System, including progress of the clinical study evaluating NPS for the treatment of seborrheic keratosis (SK), as well as the status of the 510(k) submission from earlier this year.

Another company seeking to address past pitfalls of stem cell therapies is Pluristem Therapeutics, Inc. (NASDAQ: PSTI) is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. Pluristem's products include PLX-PAD and PLX R18. The Company's PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. This process allows the cells to be expanded rapidly while remaining healthy and potent cells that can secrete therapeutic biomolecules. The Company's PLX products are administered using a standard needle and syringe. PSTI recently announced that Austria's regulatory health agency, the Austrian Agency for Health and Food Safety (AGES), had cleared Pluristem to begin enrollment in Austria for its pivotal Phase III trial of PLX-PAD cells to treat critical limb ischemia.

In other stem cell news:

Cytori Therapeutics, Inc. (NASDAQ: CYTX) recently announced that its STAR study assessing its Habeo Cell Therapy for the treatment of Scleroderma had failed to meet its primary endpoint at week 24 nor any of its secondary endpoints at week 24 or week 48. On the other hand, CYTX stated that there were 'clinically meaningful' improvements in both the primary and secondary endpoints of both hand function and scleroderma-associated functional disability compared to placebo in a subgroup of patients with diffuse cutaneous scleroderma, a more severe form of the disease. The company has stated that it will continue it analysis of the data before determining its next steps.

Capricor Therapeutics, Inc. (NASDAQ: CAPR) a biotechnology company developing biological therapies for Duchenne muscular dystrophy and other rare diseases, following news that Janssen Biotech, Inc. had decided not to exercise its option to exclusively license Capricor's lead candidate CAP-1002 for the development and commercialization in the field of cardiology, announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to CAP-1002, Capricor's development candidate for the treatment of Duchenne muscular dystrophy, a debilitating genetic disorder characterized by progressive weakness and chronic inflammation of skeletal, heart, and respiratory muscles. The Rare Pediatric Disease Designation, as well as the Orphan Drug Designation previously granted to CAP-1002 by the FDA, covers the broad treatment of DMD. Upon receiving market approval for CAP-1002 by the FDA, Capricor would be eligible to receive a Priority Review Voucher.

Microcap Speculators

Email: info@microcapspecualtors.com

Phone: +1-702-720-6310

Website: http://microcapspeculators.com/

DISCLAIMER: Microcap Speculators (MS) is the source of the content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MS or any company mentioned herein. The commentary, views and opinions expressed in this release by MS are solely those of MS and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MS and FNM for any investment decisions by their readers or subscribers. MS and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

MS Disclosure: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC. which owns Microcapspeculators.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC. which owns, Microcapspeculators.com may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC. which owns Microcapspeculators.com may be compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. For Full Legal Disclaimer Please use this link:http://microcapspeculators.com/disclaimer/

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MS and FNM undertake no obligation to update such statements.

Media ContactFN Media Group, LLCeditor@financialnewsmedia.com+1-(954)345-0611

SOURCE Microcapspeculators.com

Link:
The Big Deal About Stem Cell Therapies and Regenerative Medicine - PR Newswire (press release)

Read More...

Scitech | My experience with regenerative medicine – The McGill Daily (blog)

August 1st, 2017 2:44 am

Content warning: drug addiction, mental illness, disability

I remember the hot summer afternoon in July 2007 when I injured my back. It was a day that would change my life. I was 18, and taking part in a military program to qualify as a professional infantry soldier in the Canadian Armed Forces. My injuries all started during the first phase of a 10-kilometer walk, while carrying a 40-pound rucksack. As training progressed, I began to feel an odd sense of discomfort in my lower back. After I returned to my dorm later that day and unstrapped the rucksack, I felt a sharp pain going down from my lower back to my leg. Before bed, I took a couple of aspirin pills and washed them down with gin. The next morning, the pain had partly subsided, but the discomfort and feeling that something was wrong with my back stuck with me for days after. Weeks later, during another military exercise with a rucksack, I hurt my back so severely that I needed to see the nurse. At the time, I did not know that the following ten years would be comprised of pain from the moment I wake up to the moment I go to bed. This was the beginning of my struggle with chronic pain. Since then, I have been trying to find a way to cure my back, leading me to try regenerative medicine treatments such as Platelet Rich Plasma (PRP) and stem cells.

For the past ten years, Ive seen chiropractors, physiotherapists, psychiatrists, rheumatologists, osteopaths and virtually every health professional to treat my injury. I tried decompression therapy, kinesiotherapy, swimming, physiotherapy, non-steroidal anti-inflammatories drugs (NSAIDs), steroid injections, oral steroids, acupuncture, Chinese therapeutic massage, and praying but nothing worked. After various treatments fell through, what made the journey of searching for a cure even more difficult was the general apathy from medical doctors in Canada. Some medical specialists thought that the extent of my injury did not match the severity of the pain, therefore, my pain was merely an illusion. They dismissed my medical condition and recommended that I swim more or become more physically active. While some doctors believed me, they still didnt know how to help me. For almost eight years, I fought an uphill battle trying to convince medical professionals that I was worth their time and that I needed help. This struggle profoundly impacted my mental health.

I was stuck in a prison of pain from which I could not escape. 6 years after the injury, the pain has grown into a disability. There were days when I could barely walk or sit down for more than a few minutes. At times, my life felt like a nightmare. Activities most people take for granted, such as showering or cleaning a room, quickly became strenuous for me. Chronic pain also started impacting other areas of my life; my studies, my work, and even my relationships. I almost failed my first year of law school because of chronic pain. It made me start drinking again, and it put me into a state where I was consumed by narcotics and depression. After years of feeling despair and being unable to find an effective treatment through Canadas healthcare system, I started looking into private medical practice in the US in 2015.

Regenokine

In January of 2016, I went to New York, where I had my first experience with regenerative medicine. I went to NY Spine Medicine to get the same treatment that Kobe Bryant had received for his knees a few years back in 2013 Regenokine.

Regenokine is an anti-inflammatory serum made from the patients blood to suppress back and joint pain. The serum is made by taking some of the patients blood, heating it, and incubating it with zinc etched with glass beads. It is believed that the serum becomes rich in Interleukin 1 Receptor Antagonist Protein (IRAP), which is a natural anti-inflammatory. According to the medical doctors from NY Spine Clinic, once the serum is injected at the site of injury, it reduces the inflammation and speeds up the bodys own healing mechanism. Its as if you had a strong dose of Tylenol directly injected in an ankle or your back.

The treatment is recent; it was first developed by a doctor in Dusseldorf, Germany around 15 years ago. NY Spine Medicine is one of the institutes in the US that offer this treatment, and the cost of it is obscenely high. The treatment cost me around 17,000 US dollars for four consecutive days of injections.

I had around about 600 ml of blood taken out, and in the next four days had the serum re-injected into my lower back: facet joints, epidural space, and all around the lower spine. At the beginning of my treatment, the pain was at an all-time high and I could barely sit for more than 5 minutes. Every day of injections resulted in more and more of the pain dissipating. On the last day, before my last round of injections, I woke up pain-free for the first time in years. Shaken by the relief and emotions, I started crying I could not believe how good it felt to be free of pain. It was a miracle, but a short-lived one: the pain-relieving effects of the treatment only lasted for two months before my back started hurting once again.

Platelet Rich Plasma (PRP)

Few months passed after the Regenokine treatment and the memory of being pain-free started to fade away, but I still had hope. I kept dreaming of finding another treatment that could heal me completely. I began researching alternative treatments and eventually found the Centeno-Schultz Clinic in Colorado; they used Platelet Rich Plasma (PRP) and stem cells to treat back pain.

My first treatment at the clinic was an injection of PRP in my lower back, neck, and hips. PRP is very similar to Regenokine in that it is an autologous serum it is made with the patients blood. The difference is that while Regenokine works as an anti-inflammatory, the process by which PRP works is inflammatory. The doctor who treated me explained that PRP forces the body into a super inflammatory state, and as the inflammation subsides, it accelerates the reconstruction of ligaments and other tissues, which would in turn ease the pain. I had PRP injected into my sacroiliac joint, my lower back epidural space, and everywhere around my facet joints in my neck and back. In the first few days after the treatment, my pain levels flared up. However, in the next few weeks, the pain went down progressively, and I regained some degree of mobility. The most dramatic change was in my neck: the pain level went from a high 6-7 out of 10 to nearly a 1 within a few days. After a month, my lower back and hips felt as if they were almost healed. Although the effect of the treatment was not as dramatic as Regenokine, it lasted for a few months. I went from limping and barely being able to function to being able to play sports and go to class again. Unfortunately, like Regenokine, the healing effects of PRP were temporary. The treatment cost me around 10,000 US dollars.

Stem cells

Stem cell treatment was my last hope with regards to regenerative medicine. On May 28, I flew to the Cayman Islands for my stem cell treatment with a clinic affiliated with Centeno-Schultz Clinic. Like PRP and Regenokine, the stem cell treatment was autologous. I had three huge syringes of bone marrow aspirated from my hip bone. Mesenchymal stem cells were extracted from the bone marrow and cultivated to grow. Mesenchymal stem cells are multipotent stem cells that can transform into different types of cells depending on the situation. In my case, the stem cells were injected inside of my L5-S1 intervertebral disc with the hope that they would transform into disc tissue and help my lumbar spine heal.

The first few days after the operation, the pain was almost unbearable without oxycodone, a narcotic. It was nearly impossible to walk, bend forward, or even dress myself. The doctor informed me that I would see my pain flare up in the following four weeks, but in time, I would regain range of motion. I was also told that eventually my body is likely to be healed a hundred percent. The results are promising thus far. It has been almost three weeks since the treatment, and I have already gained back mobility and functionality. There is something changing in my back. I used to be in pain from morning to night, now after a good night of sleep, I usually wake up free from pain. In the morning, there is slight discomfort in my hip and lower back area, but no pain until I move too much or sit for too long. It takes four to six months to evaluate the full result, which seem hopeful. The stem cell treatment for my lower back and hip cost 29,000 US dollars.

Regenerative medicine does work amazingly well, but its drawback is in its exorbitant price and inaccessibility in Canada. I believe regenerative treatment is the future of medicine, and hope that the three treatments are made available in Canada as soon as possible. In total, I spent over 70,000 Canadian dollars just for my three treatments. No one should have to pay that much to live free of pain. Health is crucial to happiness, and it should never be the privilege to the only few who can afford expensive medical trips abroad.

An earlier version of this article stated thatNY Spine Medicine is the only institute in the US that offers Regenokine. In fact, there are other institutes in the US that offer the treatment. The Daily regrets the error.

Sami Ellaia is a 3L student at the Faculty of Law. To reach him, please contact sami.ellaia@mail.mcgill.ca.

The rest is here:
Scitech | My experience with regenerative medicine - The McGill Daily (blog)

Read More...

Prevent issues through lifetime of medical care – The Lima News – Lima Ohio

August 1st, 2017 2:43 am

Primary care is where preventative medicine takes place. It is the job of your primary care provider or family doctor to help you prevent illness or disease from occurring. Your health and well-being is our No. 1 priority. Our goal is to protect you from disease, promote and maintain your good health and prevent disability or even death. Preventative medicine involves many things from the simple to the complex and from the young to the elderly.

As a primary care provider, it is my responsibility to manage my patients chronic medical conditions and provide information and education on how to prevent chronic illness. This is accomplished through resources and one-on-one teaching about healthy lifestyle choices and preventative screenings.

Starting with the very young, well-child examinations are vital to ensure the child is growing and developing as a normal child should. As a primary care provider, I measure developmental milestones with each year of age. These exams occur from the time the child is born until the adolescent becomes an adult at 18 years of age. Vision and hearing screening as well as immunizations are an important part of preventing disease and keeping children well. Dental screenings are essential to prevent cavities and other more serious mouth issues. Parents are educated on the proper nutrition, activities and healthy habits that will help children learn and grow. This is where prevention starts! Teaching children good healthy habits now prevents them from becoming obese, having type 2 diabetes, joint problems, cavities and many other ailments. Mental health screenings are also performed as children grow and become more like adults during their middle and high school years.

Young adults are the next area of focus for preventative medicine. Similar to children, hearing and vision screenings are performed and good dental health habits are encouraged by keeping regular checkups. Immunizations continue with young adults to include HPV, meningitis, TDAP and annual flu vaccines. Sexually transmitted disease screenings and PAP smears begin with young adults. Educating young adults on alcohol, tobacco and drugs continues. Many aspects of safety to prevent accident or injury are discussed as well. All of the education provided to children continues into adulthood, with emphasis on issues like diet, exercise and avoiding risky behaviors.

Middle age is another very important era where preventative medicine continues to build. In addition to the preventative topics already shared, patients now become more regularly engaged with regard to routine check-ups to monitor weight, blood pressure and blood work to screen for high cholesterol or even thyroid issues. Mammograms to screen for breast cancer, PSA levels/prostate exams to screen for prostate cancer, PAP smear exams for cervical cancer screening and annual immunizations are done. Chest X-rays and low dose CT scans of the lungs are completed for smokers and smoking cessation options are discussed and encouraged. Screening for alcohol abuse is involved as well.

As we continue to age and approach our senior years of life, preventative medicine remains crucial. Pneumonia and shingles vaccine are very important in this age group as these immunizations can help prevent these infections from occurring or reduces the severity if they do occur. In addition, DEXA scans to monitor bone density looking for osteoporosis begin. This is the top of the pyramid, so to speak, as all of the other things we taught the little ones in the very beginning of life are the base.

Preventative medicine expands throughout the lifespan from infancy to the elderly. There are many areas of prevention that I have not covered in this short article, so it is vital to have an appointment scheduled with your primary care provider or family physician. Your health truly is your wealth. Making routine visits with your primary care provider when you are healthy could prevent you from a long-term chronic illness in the future.

Dr. Lorina Zenz is a certified nurse practitioner with Lima Memorial Internal Medicine & Family Healthcare.

See original here:
Prevent issues through lifetime of medical care - The Lima News - Lima Ohio

Read More...

Research Affirms the Health Benefits of Elizabeth Bennet’s Favorite Exercise – Verily

August 1st, 2017 2:43 am

When it comes to exercise, most of us think that we have to put on workout gear or break a sweat to count toward our cardio goals. Luckily, for the fitness-averse, research is proving that Lizzy Bennet had it right all along: All we really need is to go for a walk.

Extensive research proves that walking puts off heart disease, high blood pressure, and strokes. It can even help you live longer! A University College London meta-analysis found that walking reduced the chance of dying during the study period by 32 percent and the risk of cardiovascular events by 31 percent.

Think you need to power walk to get these results? Not quite. The positive results affected participants who walked as few as five and a half miles per week at a pace of about two miles per hour (thats thirty minutes per mile!). So even your casual strolls can do good for your heart.

Consistent walking prevents joint pain and your likelihood of getting painful arthritis and osteoporosis. An American College of Rheumatology study found that most adults with arthritis walk less than 1,500 steps a day (under one mile). Tripling this amount to 4,500 steps a day protected the participants from developing arthritic limitations. These dailystep goals are so doable that they can easily fit into your usual schedule.

Theres a reason whywalking it offis advisedand workswhen youre stressed. Walking reduces your stress hormones, and various studies, including research published in the American Journal of Preventative Medicine, have found that it also eases depression. In this study, women with mild to moderate depression who walked for two hundred minutes a week (about half an hour a day) experienced improved mental health, physical functioning, energy, and social skills. Even if you dont suffer from clinical depression or anxiety, walking can help lighten your worries and your mood.

Any form of exercise helps you maintain a healthy weight, but walking is an easy way to keep it in check. Researchersat Stanford University found that the amount of daily walking activity is strongly tied to obesity levels around the world. Cities where people have healthy walking habits (4,600-6,000 average daily steps) also have lower obesity levels.

On wishing to see her sister Jane, Lizzy tells her father,I do not wish to avoid the walk.The distance is nothing when one has a motive; only three miles. I shall be back by dinner." We should all take such a casual attitude toward a strollso walk with purpose to a healthier and happier you.

Photo Credit: YouTube

See the original post:
Research Affirms the Health Benefits of Elizabeth Bennet's Favorite Exercise - Verily

Read More...

Norwalk grad comes home as new family physician – Norwalk Reflector

August 1st, 2017 2:43 am

As a child growing up, if she needed to see a doctor, it was Dr. James Gottfriedshe would visit. Now after graduating with her undergraduate from University of Kentucky and doctorate from Ohio University, Tinker is returning to her hometown to practice as a family physician alongside Gottfried.

As a family physician who started in her new position Monday, Tinker said she will take care of everyone from birth to the very end at geriatric age and everything in the middle, but that wasnt her original plan. In fact, when she started college, she planned on working with animals rather than people.

To be honest, I originally went to school to be a horse veterinarian, Tinker said. It is quite a change. So I started working as a veterinary technician in Kentucky and what I loved was when pets came in and the family was there. What I realized was I was really enjoying the human interaction I was getting.

Thats when she started thinking maybe working with people would be a good change.

So I started thinking about that and at the same time I was pretty interested in preventative medicine and eating well, eating properly to nourish the body on its own without a lot of other medicine, she said. So that just got me on the right track.

Tinker said shesreally excited to be living in and serving her home community.

As a family physician I do a lot of prevention and preventative care, she said.

I look forward to helping to improve the health of our community, whether that be eating better, exercising more, preventing the onset of chronic disease, making sure kids get all the immunizations needed (or) setting people up for a good, healthy life. Thats my main goal.

Tinker is accepting new patients and will serve with Dr. Gottfried at Northern Ohio Family Practice, a private physicians group which is able to do its own lab work, osteopathic manipulation (like chiropractic care) and other services in addition to the regular doctor visits. Nothern Ohio Family Practice is located at 257 Benedict Ave., Building C, Suit 1.

Tinker is available from 8 a.m. to 5 p.m. Monday, Tuesday and Friday; 8 a.m. to 8 p.m. Thursdays and from 8 a.m. to noon some Saturdays.

See the original post here:
Norwalk grad comes home as new family physician - Norwalk Reflector

Read More...

Regular Alcohol Drinkers Have a Lower Risk of Diabetes – ScienceAlert

August 1st, 2017 2:42 am

There's a new checkmark in the 'drinking isn't all bad for you' column.

According toa new study that looked at more than 70,000 Danish people, those who drink small to moderate amounts of alcohol on a frequent basis are less likely to develop diabetes than people who don't drink at all.

To be clear, these results shouldn't be seen as licence or encouragement to drink freely as a health-promoting exercise.

But they do provide further evidence that, for some reason, people who drink moderately are less likely to suffer from certain illnesses, includingsome cardiovascular diseasesand type-2 diabetes.

For the new study, researchers wanted to see how much alcohol consumption was associated with the lowest diabetes risk, and determine whether the type of alcohol or the frequency that people drank mattered.

Using data from the Danish Health Examination Survey, they looked at the drinking habits of 28,704 men and 41,847 women, and tracked whether those people developed diabetes within approximately five years.

The researchers excluded anyone who already had diabetes, was pregnant at the start of the study, and didn't provide information on their alcohol consumption.

The results showed that the study participants least likely to develop diabetes drank 3-4 days a week. For men, those who drank 14 drinks per week had the lowest risk, as the chart on the left shows below.

For women, those who drank nine drinks per week had the lowest risk, as the right-hand chart shows.

As the U-shaped risk curve shows, study participants who didn't drink at all seemed to have a higher risk of developing diabetes. People who drank moderately had a lower risk, up to a certain point - after that, risk started to rise again.

Even heavy drinkers (up to 40 drinks per week for men and 28 drinks per week for women), however, still had a lower risk of developing diabetes than teetotalers.

The lowest risk was associated with drinking that was spread out throughout the week, rather than occurring in the same day or two.

The type of alcohol mattered too. Men and women who drank wine had the lowest diabetes risk. For men, beer was also associated with a lower risk.

Spirits didn't seem to affect risk for men, but women who drank seven or more drinks of spirits a week had an increased risk of developing diabetes.

A brief but important aside ondiabetes: The design of this study didn't allow researchers to say whether drinkers had a lower risk of developing type-2 diabetes or type 1.

Type 2 is generally caused by lifestyle factors and prevents the body from using insulin, whereas type 1 cannot be prevented since the body simply doesn't produce enough insulin.

The researchers say their study should refer to type-2 diabetes, since their results held true even if they eliminated anyone under 40 (by which point the vast majority of people with type-1 diabetes already have it).

So what's going on here?

Tempting as it might be to say that drinking lowers diabetes risk, we can't say that. All we know is that people - Danes, at least - who drink regularly develop diabetes less frequently.

It's possible that this is because people who drink in moderate quantities tend to be healthier in the first place than people who don't drink at all.

The researchers tried to calculate for these effects - they accounted for things like body mass index, physical activity, smoking status, and family history - but it's always possible that results were still skewed in some way.

There isa hypothesis that moderate drinking may improvesome aspects of health by lowering blood pressure and dilating blood vessels, but it's not certain whether that plays a role.

There are a number of other complicating factors, too. On the one hand, most people under-report their drinking, meaning that people may actually be drinking more than they reported.

Also, this was a population study in Denmark. Different results might be found in non-Scandinavian populations (especially non-white groups, manywhich have a higher risk of developing diabetes).

When it comes to alcohol and health, we know that drinking too much isn't healthy.

Alcohol consumption has been shown to increase the riskof certain cancers - a recent new report found a link between an increased risk of breast cancer and drinking as little as one glass of wine or beer each day.

The researchers behind this study aren't advocating for drinking as a means of health promotion. But at least in regard to diabetes, drinking what's considered a moderate amount throughout the week seems to be fine.

This article was originally published by Business Insider.

More from Business Insider:

View original post here:
Regular Alcohol Drinkers Have a Lower Risk of Diabetes - ScienceAlert

Read More...

As Diabetes Increases, a Vegetable Could Help – VOA Learning English

August 1st, 2017 2:42 am

From VOA Learning English, this is the Health & Lifestyle report.

Diabetes is a serious, chronic disease on the rise around the world. And, not everyone can take the medication that treats it. However, researchers have discovered that a compound found in a common vegetable might help treat diabetes.

In 2016 the World Health Organization published its Global Report on Diabetes. It says the number of diabetic adults rose from 108 million in 1980 to 422 million in 2014.

Diabetes happens in two ways. If the body does not produce enough of a hormone called insulin it is called Type 1. Type 2 diabetes is when the body cannot effectively use the insulin it produces.

Insulin controls levels of sugar in the blood.

Over time, diabetes can damage the heart, blood vessels, eyes, kidneys and nerves. Diabetes is a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation. It can lead to an early death.

India is one of the countries that could be facing a public health crisis as cases of diabetes increase. Amit Jain is a children's doctor in that country. He says obesity is one of the main reasons people get Type 2 diabetes.

However, children who are not obese can also get diabetes.

Rohin Sarin is a regular 15-year old kid. He goes to school. He likes sports. But unlike most children, four times a day he has to take a shot of insulin.

Rohin has type 2 diabetes.

"Sometimes it affects me negatively like if I just play a lot and I don't eat my food properly; then my sugar goes down. So, then I feel dizzy and I am not able to play the sport properly."

About 300 million people around the world have type-2 diabetics. A large percentage of these people cannot take a drug used to treat this disease.

The drug metformin is a first-line therapy. This means it is often the first drug doctors give their patients. However, the drug has side effects. It can damage the kidneys and upset the stomach.

Enter broccoli.

This vegetable has a chemical compound called sulforaphane. And in testing, this compound appears to work as well as the drug metformin at reducing blood sugar levels in diabetics.

Anders Rosengren, a doctor at the University of Gothenburg in Sweden, led the study.

"We think this is very exciting because there have been so many claims over the years of different food, dietary components having different health effects. But here, we have really scientifically-based proof that it has an effect on type-2 diabetes."

Dr. Rosengren and his team experimented with 97 type-2 diabetes patients. All were treated with metformin. But one group of the patients were also given sulforaphane every day for three months. The other patients were given a placebo.

On average, the participants who were given the broccoli medicine saw their blood glucose drop by 10% more than those who took the placebo. The broccoli pill was most effective in the patients who were obese. They started with higher glucose levels than the others.

Dr. Rosengren says that next he wants to study the effects sulforaphane has on pre-diabetic patients. These are people who have not yet taken the drug metformin.

"If you were to have people without metformin at all, it might be that the sulforaphane effect might be even stronger."

The researchers published their finding in the journal Science Translational Medicine.

But do not think that just eating broccoli is enough to prevent or treat diabetes. You would have to eat about five kilograms every day to get enough sulforaphane.

The study patients got a pill containing a concentrated form of the broccoli compound. It is about 100 times stronger than the amount found in broccoli.

But, for diabetics who hate broccoli, that could be welcome news.

And that's the Health & Lifestyle report. I'm Anna Matteo.

Reports from VOAs Kevin Enochs and Jessica Berman contributed to this story adapted by Anna Matteo for Learning English. Caty Weaver was the editor.

_____________________________________________________________

_____________________________________________________________

insulin n. a substance that your body makes and uses to turn sugar into energy

pancreas n. a large gland of the body that is near the stomach and that produces insulin and other substances that help the body digest food

negatively adv. harmful or bad : not wanted

sugar medical noun the amount of sugar present in a person's blood at a particular time

dizzy adj. having a whirling sensation in the head with a tendency to fall : mentally confused

dietary adj. of or relating to a diet

component n. one of the parts of something (such as a system or mixture) : an important piece of something

concentrated adj. made stronger or more pure by removing water

placebo medical noun a pill or substance that is given to a patient like a drug but that has no physical effect on the patient

Continued here:
As Diabetes Increases, a Vegetable Could Help - VOA Learning English

Read More...

Dining with Diabetes class offered in September – Lock Haven Express

August 1st, 2017 2:42 am

JERSEY SHORE Learning that you have diabetes can be overwhelming at first. There are many new things to learn and it can be difficult to know where to start. Dining with Diabetes is a program offered by Penn State Extension.

It will help you to understand some of the most important things you need to know about how to manage your diabetes.

Extension Educators will lead discussions addressing important numbers you need to know, planning healthy meals and physical activity.

Classes are offered weekly for four weeks, with a three-month follow-up class. Each class offers food demonstrations and tastings, physical activity, ideas to take home, and discussions regarding important information to help you manage your diabetes. Lab tests will be offered to measure A1c.

In addition to class handouts and test results, participants also receive a variety of resources, including a complete collection of Dining with Diabetes recipes. If you have been told that you have pre-diabetes or Type 2 diabetes, you will want to attend this class.

The class meets at the Jersey Shore Senior Center located on 641 Cemetery St. in Jersey Shore from 12:30-2:30 p.m. in September. There is a $5 fee for the series. For more information or to register: http://extension.psu.edu/health/diabetes, 570-433-3040, or contact Brenda at the Senior Center (570-601-9591).

Deadline to register is Sept. 1.

The Pennsylvania State University encourages qualified persons with disabilities to participate in its programs and activities. If you anticipate needing any type of accommodation or have questions about the physical access provided, please contact Laurie Welch in advance of your participation or visit.

RENOVO A South Renovo man was seriously injured in a one-vehicle crash at 3:01 p.m. Sunday on Route 144 in ...

Art exhibit, sale at MillbrookMILL HALL Stage Right Millbrook and Full Circle Center have joined forces to ...

New Hope plans yard, craft showMILL HALL New Hope Fellowship Church along Route 64 in Mill Hall will have a ...

Read the original here:
Dining with Diabetes class offered in September - Lock Haven Express

Read More...

YMCA’s diabetes prevention class exceeds goals – McDowell News

August 1st, 2017 2:42 am

Recently, some folks have achieved and even exceeded their goal of losing weight and exercising more through a diabetes prevention program that is now offered at the Corpening Memorial YMCA. The participants in this class said they want other people in McDowell to realize that they too can make strides in avoiding this chronic disease.

Just a couple of years ago, a community health assessment listed diabetes as one of the most serious health problems in McDowell County.

McDowell has a higher rate of overweight adults than the rest of western North Carolina and the state as a whole and a lower rate of physical activity as well. The prevalence of self-reported adult diabetes has been rising over time in both western North Carolina and McDowell County, according to the data from the 2015 Community Health Assessment.

The assessment said diabetes also affects employability because those who cannot regulate their disease are often unable to work, creating larger problems.

Most importantly, though, it can be prevented.

For five years, the Corpening Memorial YMCA has offered its diabetes prevention program (DPP) but a certain class has made considerable strides in avoiding the disease.

This class is super successful, said Lindsey Thompson, director of population health data management. Its the most successful class in the programs history.

One of the goals for a class is for the participants to lose an average of 7 percent of their body weight. The members of this particular class lost an average of 11 percent of their body weight. They finished their year-long participation in May.

The members of this class are Abby Rumfelt, Dwayne Finley, his wife Pam Finley, Betty English, Carolyn Foster and Joe Williams. Pat Medders was their instructor.

Everyone in the class is pre-diabetic. That means their blood glucose levels are higher than normal but not yet high enough to be diagnosed as diabetes. Doctors sometimes refer to pre-diabetes as impaired glucose tolerance (IGT) or impaired fasting glucose (IFG), depending on what test was used when it was detected. This condition puts you at a higher risk for developing type 2 diabetes and cardiovascular disease, according to the American Diabetes Association.

You have an upfront assessment, said Dwayne Finley. They give you a physical assessment. They look at your A1C and your fasting blood sugar and your family history.

The class takes about an entire year to complete. The participants meet once a week for the first 16 weeks and then biweekly for three times. They then meet once a month for the remaining six months. Each class lasts around an hour.

During the course of the year, the participants learn about eating healthier, which includes checking the labels for foods in the store. What to look for and talk about the importance of watching the types of food you eat, said Dwayne Finley.

The participants are also taught the importance of physical activity. As part of the regimen, they can exercise at the Y or elsewhere. Exercise can mean walking, biking, swimming, climbing or working out. They can exercise together or do it on their own.

Medders lead her class and encouraged them to achieve their goals. She formerly taught Spanish at McDowell High School and has taught classes with DPP for two and a half years now.

Its not a diet, she said. Its a lifestyle change.

In addition to losing body weight, another major goal is for the members to work up to participating in 150 minutes of physical activity per week.

For some members, this seemed rather daunting.

When I started, I could hardly do a couple of laps on the indoor track at the Y, said Rumfelt. Now, I can do a mile and a half and not think about it. And the other people in the group are inspiring.

The support system is a large part of the success, said Thompson.

This particular class exceeded that goal as well and even doubled it. That class did an average of 300 minutes of physical activity per week.

Thompson and the graduates of this class hope that other folks will take advantage of the DPP offered at the local YMCA. The cost to participate in the year-long class is $429 and that includes a family membership in the Y. As an incentive for participating, you get a free family membership. Financial aid is available.

Two new classes will start in August and they will be available for both day and night time.

Andie McClain is the programs coordinator. She evaluates each person before they can participate in the class.

Weve already got a couple of participants in it, said McClain, adding interested folks should contact her soon before the class fills up.

For more information, contact the Corpening Memorial YMCA at 659-9622. You can reach Andie McClain at 575-2901.

Originally posted here:
YMCA's diabetes prevention class exceeds goals - McDowell News

Read More...

Health Matters: A Program to Help Manage Diabetes – NBC2 News

August 1st, 2017 2:42 am

It was 12 years ago when Scott Fine was diagnosed with type two diabetes. I went to my doctor I started on medication and he told me I needed to change my food habits and start exercising. I didnt comply. I was very non-compliant at the time. So, I struggled for the last 12 years.

Last December, after another visit to the emergency room for high blood sugar, Scott had a wakeup call and decided it was time to make some lifestyle changes. I said ok I think Im ready now. The nurse told me Lee Health Solutions has a class that you can take and you really need to take it. So I called and I enrolled and that was the beginning of something really great in my life.

The diabetes program is a three day class explaining how diabetes affects the body and how patients can manage their diabetes through medication and healthy lifestyle changes. We try to paint a broad picture of how to make healthy choices. We teach reading food labels, we talk a little bit about carb counting, we always have to talk about fats in the diet, and we try to paint a broad picture of what it is to eat healthy, said Sharon Tilbe, a diabetes coordinator at Lee Health.

Just four months after the class Scott lost 26 pounds, and for the first time in 12 years, his blood work is in the normal range. My food habits have totally changed. Im eating all good stuff now. No more Oreos and fast food and bad stuff. Ive started exercising. I do about an hour to an hour and half a day of exercise, said Scott.

The class teaches exercises, meal planning, and how to improve blood sugar levels. It was hard at first, but I found the way, and thats because of Lee Health Solutions, said Scott.

The diabetes program can give anyone living with type two diabetes a better quality of life.

More:
Health Matters: A Program to Help Manage Diabetes - NBC2 News

Read More...

Page 980«..1020..979980981982..9901,000..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick